Triple Combination Therapy in Hypertension: The Antihypertensive Efficacy of Treatment with Perindopril, Amlodipine, and Indapamide SR

被引:29
作者
Pall, Denes [1 ]
Szanto, Ildiko [1 ]
Szabo, Zoltan [1 ]
机构
[1] Univ Debrecen, Ctr Clin, Dept Med, H-4032 Debrecen, Hungary
关键词
CONVERTING ENZYME-INHIBITORS; TYPE-2; DIABETES-MELLITUS; BLOOD-PRESSURE; MANAGEMENT; METAANALYSIS; GUIDELINES; RATIONALE; MORTALITY; BLOCKERS; OUTCOMES;
D O I
10.1007/s40261-014-0223-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The blood pressure (BP) of most patients on antihypertensive monotherapy or bitherapy remains uncontrolled. Our study evaluated the efficacy of triple therapy with perindopril, amlodipine, and indapamide sustained release (SR) in patients with uncontrolled hypertension on previous antihypertensive therapy. This 4-month, multicenter, prospective, observational, open-label study included patients switched from previous antihypertensive therapy to triple therapy with perindopril, amlodipine, and indapamide SR. The main outcome was change in office BP from baseline to 4 months, as well as changes in 24-h ambulatory BP monitoring (ABPM) parameters in a subgroup of patients. Age was 62.8 +/- A 11.3 years in 6,088 patients (55 % were male). Office BP at baseline was 158.1 +/- A 13.0/92.6 +/- A 8.8 mmHg. By 4 months, office BP decreased by 26.7 +/- A 13.3/12.9 +/- A 9.4 mmHg (p < 0.001). ABPM was performed in 62 patients. In these patients, 24-h systolic BP decreased (from 138.7 +/- A 12.5 to 125.5 +/- A 12.8 mmHg), as did 24-h diastolic BP (from 77.5 +/- A 11.4 to 70.4 +/- A 8.7 mmHg) (both p < 0.0001). Heart rate remained unchanged. In patients previously on renin-angiotensin-aldosterone system (RAAS) inhibitor/amlodipine, 24-h ambulatory systolic and diastolic BP decreased from 136.9 +/- A 12.8 to 125.4 +/- A 13.3 mmHg (p = 0.0003) and from 76.3 +/- A 12.6 to 70.2 +/- A 9.5 mmHg (p = 0.0005). In those previously on RAAS inhibitor/hydrochlorothiazide, 24-h ambulatory systolic and diastolic BP decreased from 137.8 +/- A 12.7 to 122.7 +/- A 15.4 mmHg (p = 0.0039) and from 73.6 +/- A 9.4 to 65.7 +/- A 7.3 mmHg (p = 0.002). Most (74 and 80 %, respectively) patients reached target ABPM values (< 130/80 mmHg). A triple combination of perindopril, amlodipine, and indapamide SR controlled BP effectively in hypertensive patients uncontrolled by previous antihypertensive monotherapy or bitherapy, including RAAS inhibitor/amlodipine or RAAS inhibitor/hydrochlorothiazide combinations.
引用
收藏
页码:701 / 708
页数:8
相关论文
共 50 条
[41]   ALISKIREN/AMLODIPINE COMBINATION FOR THE TREATMENT OF HYPERTENSION [J].
Billecke, S. S. ;
Marcovitz, P. A. .
DRUGS OF TODAY, 2011, 47 (06) :403-417
[42]   Full-dose Perindopril/Indapamide in the Treatment of Difficult-to-Control Hypertension: The FORTISSIMO Study [J].
Karpov, Yuri Aleksandrovich .
CLINICAL DRUG INVESTIGATION, 2017, 37 (02) :207-217
[43]   Efficacy of combination therapy with telmisartan plus amlodipine in patients with poorly controlled hypertension [J].
Bekki, Hisatoshi ;
Yamamoto, Kiichiro ;
Sone, Masayoshi ;
Homma, Tomoki ;
Nakata, Masashi ;
Nohara, Masatoshi ;
Fukami, Kei ;
Okuda, Seiya ;
Yamagishi, Sho-ichi .
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2010, 3 (05) :342-346
[44]   Efficacy and Safety of Triple Therapy With Telmisartan, Amlodipine, and Rosuvastatin in Patients With Dyslipidemia and Hypertension: The Jeil Telmisartan, Amlodipine, and Rosuvastatin Randomized Clinical Trial [J].
Hong, Soon Jun ;
Jeong, Han Saem ;
Cho, Jin-Man ;
Chang, Kiyuk ;
Pyun, Wook Bum ;
Ahn, Youngkeun ;
Hyon, Min Su ;
Kang, Woong Chol ;
Lee, Jae-Hwan ;
Kim, Hyo-Soo .
CLINICAL THERAPEUTICS, 2019, 41 (02) :233-248
[45]   IMPORTANCE OF A FIXED COMBINATION OF TELMISARTAN AND AMLODIPINE FOR THE TREATMENT OF HYPERTENSION [J].
Ahrens, K. ;
Bramlage, P. .
DRUGS OF TODAY, 2010, 46 (05) :339-350
[46]   The FORTISSIMO Program: Advantages of Fixed Full Dose Combination of Perindopril Arginine and Indapamide in the Treatment of Poorly Controlled Arterial Hypertension [J].
Karpov, Yu. A. .
KARDIOLOGIYA, 2013, 53 (03) :37-43
[47]   Combined Therapy of Arterial Hypertension With the Fixed Combination of Perindopril Arginine/Amlodipine in Real Clinical Practice: the Organization and the Main Results of the Program CONSTANTA [J].
Kobalava, Zh. D. ;
Kotovskaya, Yu. V. ;
Lukyanova, E. A. .
KARDIOLOGIYA, 2013, 53 (06) :25-34
[48]   Efficacy of Single-Pill, Triple Antihypertensive Therapy in Patients with Uncontrolled Hypertension: A Systematic Review and Meta-analysis [J].
Habboush, Shady ;
Sofy, Ahmed Adel ;
Masoud, Ahmed Taher ;
Cherfaoui, Omar ;
Farhat, Abdullah Mohamed ;
Abdelsattar, Ahmed Taha ;
Elmoursi, Ahmed .
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2022, 29 (03) :245-252
[49]   Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: amulticenter, randomized, double-blind, controlled trial [J].
Mourad, Jean-Jacques ;
Amodeo, Celso ;
de Champvallins, Martine ;
Brzozowska-Villatte, Romualda ;
Asmar, Roland .
JOURNAL OF HYPERTENSION, 2017, 35 (07) :1481-1495
[50]   AMLODIPINE AND LISINOPRIL IN COMBINATION FOR THE TREATMENT OF ESSENTIAL-HYPERTENSION - EFFICACY AND PREDICTORS OF RESPONSE [J].
CAPPUCCIO, FP ;
MARKANDU, ND ;
SINGER, DRJ ;
MACGREGOR, GA .
JOURNAL OF HYPERTENSION, 1993, 11 (08) :839-847